Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Belluscura PLC ( (GB:BELL) ) just unveiled an announcement.
Belluscura PLC has announced the posting of a circular and notice of a General Meeting to its shareholders as part of its fundraising efforts. The General Meeting is scheduled for 28 February 2025, and the company plans to issue new shares to be traded on AIM, subject to shareholder approval. This is expected to fortify its financial position and potentially enhance its standing in the medical device sector.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company specializing in oxygen enrichment technology, which serves a wide range of industries and therapeutic applications.
YTD Price Performance: -75.68%
Average Trading Volume: 558,951
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £3.79M
See more insights into BELL stock on TipRanks’ Stock Analysis page.